Scott Dreyer - Net Worth and Insider Trading

Scott Dreyer Net Worth

The estimated net worth of Scott Dreyer is at least $3 Million dollars as of 2024-12-28. Scott Dreyer is the EVP & Chief Commercial Officer of Collegium Pharmaceutical Inc and owns about 105,902 shares of Collegium Pharmaceutical Inc (COLL) stock worth over $3 Million. Details can be seen in Scott Dreyer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Dreyer has not made any transactions after 2024-05-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Scott Dreyer

To

Scott Dreyer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Scott Dreyer owns 1 companies in total, including Collegium Pharmaceutical Inc (COLL) .

Click here to see the complete history of Scott Dreyer’s form 4 insider trades.

Insider Ownership Summary of Scott Dreyer

Ticker Comapny Transaction Date Type of Owner
COLL Collegium Pharmaceutical Inc 2024-05-24 EVP & Chief Commercial Officer

Scott Dreyer Latest Holdings Summary

Scott Dreyer currently owns a total of 1 stock. Scott Dreyer owns 105,902 shares of Collegium Pharmaceutical Inc (COLL) as of May 24, 2024, with a value of $3 Million.

Latest Holdings of Scott Dreyer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COLL Collegium Pharmaceutical Inc 2024-05-24 105,902 29.11 3,082,807

Holding Weightings of Scott Dreyer


Scott Dreyer Form 4 Trading Tracker

According to the SEC Form 4 filings, Scott Dreyer has made a total of 12 transactions in Collegium Pharmaceutical Inc (COLL) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Collegium Pharmaceutical Inc is the sale of 108,016 shares on May 24, 2024, which brought Scott Dreyer around $4 Million.

Insider Trading History of Scott Dreyer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Scott Dreyer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Scott Dreyer Ownership Network

Ownership Network List of Scott Dreyer

No Data

Ownership Network Relation of Scott Dreyer

Insider Network Chart

Scott Dreyer Owned Company Details

What does Collegium Pharmaceutical Inc do?

Who are the key executives at Collegium Pharmaceutical Inc?

Scott Dreyer is the EVP & Chief Commercial Officer of Collegium Pharmaceutical Inc. Other key executives at Collegium Pharmaceutical Inc include EVP and Chief Medical Officer Thomas B Smith , EVP and General Counsel Shirley R. Kuhlmann , and EVP & Chief Financial Officer Tupper Colleen .

Collegium Pharmaceutical Inc (COLL) Insider Trades Summary

Over the past 18 months, Scott Dreyer made 3 insider transaction in Collegium Pharmaceutical Inc (COLL) with a net sale of 141,576. Other recent insider transactions involving Collegium Pharmaceutical Inc (COLL) include a net sale of 70,825 shares made by Shirley R. Kuhlmann , a net sale of 73,125 shares made by Joseph Ciaffoni , and a net sale of 28,985 shares made by Garen G Bohlin .

In summary, during the past 3 months, insiders sold 0 shares of Collegium Pharmaceutical Inc (COLL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 343,814 shares of Collegium Pharmaceutical Inc (COLL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 343,814 shares.

Collegium Pharmaceutical Inc (COLL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Collegium Pharmaceutical Inc Insider Transactions

No Available Data

Scott Dreyer Mailing Address

Above is the net worth, insider trading, and ownership report for Scott Dreyer. You might contact Scott Dreyer via mailing address: 780 Dedham Street, Suite 800, Canton Ma 02021.

Discussions on Scott Dreyer

No discussions yet.